Embryotoxicity of orally administered chromium in mice: exposure during the period of organogenesis.
Administration of chromium (VI)(250, 500 and 750 ppm as potassium dichromate) via drinking water during organogenesis (days 6-14 of gestation) in mice revealed embryo- and fetotoxic effects. Reduced fetal weight, retarded fetal development, number of fetuses (live and dead) per mother and high incidences of dead fetuses and resorptions in treated mothers in the highest dosed group were evident. No significant gross structural abnormalities were observed in any of the fetuses of chromium (VI)-treated mothers. Significant incidences of reduced ossification were found in the highest dosed group. Chromium levels were increased in a dose-dependent manner in maternal blood, placenta and fetuses. The present study suggests a risk to the developing embryo if the mother is exposed to a sufficiently high concentration of chromium (VI) through drinking water during the period of organogenesis.
Junaid
M
M
Embryotoxicology Laboratory, Industrial Toxicology Research Centre, Lucknow, India.
Murthy
R C
RC
Saxena
D K
DK
D000014:Abnormalities, Drug-Induced; D000284:Administration, Oral; D000818:Animals; D001842:Bone and Bones / Q000002:abnormalities; D002857:Chromium / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000633:toxicity*; D004326:Drinking; D004622:Embryo, Mammalian / Q000187:drug effects*; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D005333:Fetus / Q000737:chemistry / Q000187:drug effects; D008297:Male; D051379:Mice; D010920:Placenta / Q000737:chemistry; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D014018:Tissue Distribution
D002857:Chromium